Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-24 @ 11:43 PM
NCT ID: NCT05147051
Eligibility Criteria: Inclusion Criteria: 1. Signed and dated written Informed Consent (if unconscious due to a critical condition, the decision is made by a Council consisting of 3 physicians) 2. Male and female patients aged 18-70 3. Critical illness ((shock (including traumatic, hypovolemic), major trauma, acute massive blood loss, acute complicated surgical diseases of the abdominal organs) accompanied by metabolic acidosis, defined as serum bicarbonate \<22mmol/L 4. pH of arterial blood 7.20-7.35, inclusive 5. Planned volume of infusion \>= 1500 ml per day 6. Interval between admission to the ICU and randomization \<24 hours Exclusion Criteria: 1. Pregnant and lactating women 2. Known hypersensitivity to any component of the study drug / placebo 3. Chronic kidney disease stage C5 (end-stage renal failure) 4. Acute hepatic failure (ALT \> 15 upper normal limits) or liver cirrhosis 5. Traumatic brain injury accompanied by cerebral edema 6. Previously diagnosed mental illness 7. Any chronic disease in the terminal stage with a life expectancy of \< 3 months 8. HIV infection 9. Clinically significant cardiovascular disease (unstable angina pectoris or angina pectoris of functional class III or higher; chronic heart failure III - IV class according to NYHA; acute myocardial infarction within 6 months before screening) 10. Extremely low or extremely high body fat 11. Infusion sodium bicarbonate, sodium bicarbonate, trometamol, Sterofundin, Quintasol, Ringer's lactate (Hartmann's solution) within 6 hours before screening 12. Acute respiratory acidosis 13. Poisoning with chemical compounds causing metabolic acidosis 14. Alcohol in saliva at screening \>= 0.5 pro mille 15. Previously diagnosed chronic obstructive pulmonary disease
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT05147051
Study Brief:
Protocol Section: NCT05147051